Description

6-Cyclopentyl-2-Oxo-1,2-Dihydropyridine-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its bicyclic pyridone-carboxylic acid structure. This compound is of significant commercial value for its role as a key building block in the synthesis of novel, complex active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of proprietary drug candidates, particularly those targeting neurological or metabolic disorders.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Used in the final stages or penultimate steps for constructing complex molecular architectures in active pharmaceutical ingredients.
• Chemical Reference Standard: Employed as a high-purity standard for analytical method development, validation, and quality control in regulatory filings.
• Bioconjugation & Probe Development: The carboxylic acid moiety allows for derivatization, making it useful for creating biochemical probes or targeted drug conjugates.

Basic Information

Product Name	6-Cyclopentyl-2-Oxo-1,2-Dihydropyridine-4-Carboxylic Acid
CAS No.	1368348-22-4
Molecular Formula	C11H13NO3
Molecular Weight	207.23 g/mol
Synonyms	6-Cyclopentyl-4-carboxy-2-pyridone; 4-Pyridinecarboxylic acid, 1,2-dihydro-6-cyclopentyl-2-oxo-; 6-Cyclopentyl-1,2-dihydro-2-oxo-4-pyridinecarboxylic acid; 6-Cyclopentyl-2-oxo-1,2-dihydro-4-pyridinecarboxylic acid; 2-Hydroxy-6-cyclopentyl-4-pyridinecarboxylic acid; 6-Cyclopentyl-2-hydroxynicotinic acid; 6-Cyclopentyl-2-oxo-1,2-dihydropyridine-4-carboxylate (anion form)
EINECS	Contact for details

Quality Control

Our production of 6-Cyclopentyl-2-Oxo-1,2-Dihydropyridine-4-Carboxylic Acid adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. All material is manufactured and handled in a controlled environment suitable for pharmaceutical intermediates. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with each shipment to support your regulatory and R&D requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere for long-term storage to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.